Abstract |
One hundred fifty-one men with genital ulcer disease were assigned randomly to treatment with one of five oral antimicrobial regimens: (1) sulfadimidine (1 g four times daily for seven days); (2) tetracycline (500 mg four times daily for seven days); (3) trimethoprim-sulfamethoxazole ( TMP-SMZ; 160 mg of TMP and 800 mg of SMZ twice daily for seven days); (4) doxycycline (300 mg as a single dose); or (5) TMP- sulfametrole (640 mg of TMP and 3,200 mg of sulfametrole once as a single dose). Haemophilus ducreyi was isolated from 81 (54%) of the men, and 35 strains were available for testing of antimicrobial susceptibility. The TMP-SMZ and TMP- sulfametrole regimens were more effective than sulfadimidine, tetracycline, or single-dose doxycycline in curing ulcers. Only one of 35 strains tested was susceptible to tetracycline (less than or equal to 8 mg/liter), and only ten of 35 strains were susceptible to doxycycline (less than or equal to 4 mg/liter), whereas all were susceptible to trimethoprim (less than or equal to 2 mg/liter). The correlation between in vitro susceptibility and bacteriologic response to the antimicrobial agents requires further investigation. In particular, sulfonamide resistance did not always identify failure to respond to sulfadimidine.
|
Authors | M V Fast, H Nsanze, L J D'Costa, P Karasira, I W Maclean, P Piot, W L Albritton, A R Ronald |
Journal | Sexually transmitted diseases
(Sex Transm Dis)
1983 Jan-Mar
Vol. 10
Issue 1
Pg. 1-6
ISSN: 0148-5717 [Print] United States |
PMID | 6601847
(Publication Type: Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Sulfanilamides
- Sulfamethazine
- Trimethoprim
- sulfametrole
- Tetracycline
- Sulfamethoxazole
- Doxycycline
|
Topics |
- Chancroid
(drug therapy)
- Doxycycline
(pharmacology, therapeutic use)
- Drug Therapy, Combination
- Haemophilus ducreyi
(drug effects)
- Humans
- In Vitro Techniques
- Male
- Species Specificity
- Sulfamethazine
(pharmacology, therapeutic use)
- Sulfamethoxazole
(pharmacology, therapeutic use)
- Sulfanilamides
(pharmacology, therapeutic use)
- Tetracycline
(pharmacology, therapeutic use)
- Trimethoprim
(pharmacology, therapeutic use)
|